S SOPHARMA

Serial Number 76571645
Registration 3039075
800

Registration Progress

Application Filed
Jan 23, 2004
Under Examination
Approved for Publication
Sep 28, 2005
Published for Opposition
Oct 18, 2005
Registered
Jan 10, 2006

Attorney Assistance

Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20060110) (Grace Period Filing)
Due: Jul 10, 2026 Grace Period - 169 days
Original deadline was Jan 10, 2026 (overdue)

Trademark Image

S SOPHARMA

Basic Information

Serial Number
76571645
Registration Number
3039075
Filing Date
January 23, 2004
Registration Date
January 10, 2006
Published for Opposition
October 18, 2005
Renewal Date
January 10, 2016
Drawing Code
3

Status Summary

Current Status
Active
Status Code
800
Status Date
Mar 18, 2016
Registration
Registered
Classes
005

Rights Holder

Sopharma AD

03
Address
16 Iliensko Shosse Str.
Sofia 1220
BG

Ownership History

Sopharma AD

Original Applicant
03
Sofia BG

Sopharma AD

Owner at Publication
03
Sofia BG

Sopharma AD

Original Registrant
03
Sofia BG

Legal Representation

Attorney
Nicholas D. Wells

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20060110)
Due Date
January 10, 2026
Grace Period Ends
July 10, 2026

Application History

33 events
Date Code Type Description Documents
Jan 10, 2025 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 26, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 26, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 18, 2016 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Mar 18, 2016 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Mar 18, 2016 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Mar 17, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 11, 2016 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jan 11, 2016 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 5, 2012 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Loading...
Mar 5, 2012 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED Loading...
Mar 1, 2012 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 10, 2012 ES8R I TEAS SECTION 8 RECEIVED Loading...
Mar 30, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 10, 2006 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 18, 2005 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 28, 2005 NPUB O NOTICE OF PUBLICATION Loading...
Jul 6, 2005 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 1, 2005 ALIE A ASSIGNED TO LIE Loading...
Jun 29, 2005 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 26, 2005 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
May 17, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 17, 2005 MAIL I PAPER RECEIVED Loading...
Mar 16, 2005 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Mar 1, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 1, 2005 MAIL I PAPER RECEIVED Loading...
Sep 1, 2004 CNRT F NON-FINAL ACTION MAILED Loading...
Aug 31, 2004 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Aug 14, 2004 DOCK D ASSIGNED TO EXAMINER Loading...
May 5, 2004 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
May 5, 2004 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 5, 2004 MAIL I PAPER RECEIVED Loading...
Feb 10, 2004 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, preparations for treatment of peripheral neuritis and neuralgia and treatment of neurological disorders, physical and mental fatigue; tonics for the nervous system; capillartonics; anti-inflammatory preparations and preparations for treatment of artery, vein and capillary diseases; nutritional supplements for improving and regulating metabolism in epithelial cells to protect them from degenerative alterations; nutritional supplements for enhancing and maintaining the status of the immune system; nutritional supplements for influencing chronic hepatitis, dystrophies and damage of the liver; dietetic substances adapted for medical use
First Use Anywhere: Jun 3, 1993
First Use in Commerce: Jun 3, 1993

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005